(Q53524831)

15 May 2018

title

Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. (English)

1 reference

15 May 2018

1 reference

1 reference

6

1 reference

15 May 2018

Wolfgang H. Oertel

7

object named as

Oertel WH

1 reference

15 May 2018

author name string

Hagell P

1

1 reference

15 May 2018

Crabb L

2

1 reference

15 May 2018

Pogarell O

3

1 reference

15 May 2018

Schrag A

4

1 reference

15 May 2018

Widner H

5

1 reference

15 May 2018

Quinn NP

8

1 reference

15 May 2018

Lindvall O

9

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

15 May 2018

published in

Movement Disorders

1 reference

15 May 2018

volume

15

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

224-229

1 reference

15 May 2018

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Cerebral implantation in movement disorders: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Engineering neurons for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

A quantitative approach to perceived health status: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

German version of the Nottingham Health Profile (NHP): translation and psychometric validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Quality of life in patients with Parkinson's disease: development of a questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C224%3A%3AAID-MDS1004%3E3.0.CO%3B2-W

10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018